Angina pectoris is a stronger indicator of diffuse vascular atherosclerosis than intermittent claudication: Framingham study

Journal of Clinical Epidemiology

Volumn 61, Issue 9, 2008, Pages 951-957

  Kannel, W B ^a   Evans, J C ^b   Piper, S ^d   Murabito, J M ^a,c  

^a FRAMINGHAM HEART STUDY   (United States)

^b BOSTON UNIVERSITY   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF HOUSTON   (United States)

Author keywords

Angina pectoris; Cardiovascular disease; Cohort study; Intermittent claudication; Prognosis; Vascular damage indicator

Indexed keywords

ADULT; AGED; ANGINA PECTORIS; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; INTERMITTENT CLAUDICATION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PRIORITY JOURNAL; STROKE; TRANSIENT ISCHEMIC ATTACK;

ADULT; ANGINA PECTORIS; ATHEROSCLEROSIS; FEMALE; HUMANS; INTERMITTENT CLAUDICATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SPHYGMOMANOMETERS;

EID: 48449094273     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2007.10.025     Document Type: Article

References (41)

1. Bowlin S.J., Medalie J.H., Flocke S.A., Zyzanski S.J., Yaari S., and Goldbourt U. Intermittent claudication in 8343 men and 21-year specific mortality follow-up. Ann Epidemiol 7 (1997) 180-187
2. Bainton D., Sweetnam P., Baker I., and Elwood P. Peripheral vascular disease: consequence for survival and association with risk factors in the Speedwell prospective heart disease study. Br Heart J. 72 (1994) 128-132
3. Smith G.D., Shipley M.J., and Rose G. Intermittent claudication, heart disease risk factors, and mortality. The Whitehall Study. Circulation 82 (1990) 1925-1931
4. McDermott M.M., Liu K., Criqui M.H., Ruth K., Goff D., Saad M.F., et al. Ankle-brachial index and subclinical cardiac and carotid disease: the multi-ethnic study of atherosclerosis. Am J Epidemiol. 162 (2005) 33-41
5. Resnick H.E., Lindsay R.S., McDermott M.M., Devereux R.B., Jones K.L., Fabsitz R.R., et al. Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality: the Strong Heart Study. Circulation 109 (2004) 733-739
6. O'Hare A.M., Katz R., Shlipak M.G., Cushman M., and Newman A.B. Mortality and cardiovascular risk across the ankle-arm index spectrum: results from the Cardiovascular Health Study. Circulation 113 (2006) 388-393
7. Newman A.B., Shemanski L., Manolio T.A., Cushman M., Mittelman M., Polak J.F., et al. Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. The Cardiovascular Health Study Group. Arterioscler Thromb Vasc Biol. 19 (1999) 538-545
8. Newman A.B., Sutton-Tyrrell K., Vogt M.T., and Kuller L.H. Morbidity and mortality in hypertensive adults with a low ankle/arm blood pressure index. JAMA 270 (1993) 487-489
9. Newman A.B., Siscovick D.S., Manolio T.A., Polak J., Fried L.P., Borhani N.O., et al. Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group. Circulation 88 (1993) 837-845
10. Lampe F.C., Whincup P.H., Wannamethee S.G., Ebrahim S., Walker M., and Shaper A.G. Chest pain on questionnaire and prediction of major ischaemic heart disease, events in men. Eur Heart J 19 (1998) 63-73
11. Bulpitt C.J., Shipley M.J., Demerovic J., Ebi-Kryston K.L., Markowe H.L., and Rose G. Predicting death from coronary heart disease using a questionnaire. Int J Epidemiol 19 (1990) 899-904
12. LaCroix A.Z., Guralnik J.M., Curb J.D., Wallace R.B., Ostfeld A.M., and Hennekens C.H. Chest pain and coronary heart disease mortality among older men and women in three communities. Circulation 81 (1990) 437-446
13. Dawber T.R., Kannel W.B., and Lyell L.P. An approach to longitudinal studies in the community: the Framingham Study. Ann N Y Acad Sci 107 (1963) 539-556
14. Cupples L.A., D'Agostino R.B., and Keily D. Some risk factors related to the annual incidence of cardiovascular disease and death using pooled repeated biennial measurements: Framingham Heart Study, 30-year follow-up (1987), US Dept. of Health and Human Services. Public Health Service, National Institutes of Health, Bethesda, MD NIH Publication No. 87-2703
15. Abbott R.D. The Framingham Study: an epidemiologic investigation of cardiovascular disease, section 37: the probability of developing certain cardiovascular diseases in eight years at specified values of some characteristics (1987), National Heart, Lung and Blood Institute, Bethesda, MD 2004
16. Chiang I.M., Gelman R., and Pagano M. Corrected group prognostic curves and summary statistics. J Chron Dis 35 (1982) 669-674
17. Mohler E.R. Peripheral arterial disease: identification and implications. Arch Intern Med 163 (2003) 2306-2314
18. O'Riordain D.S., and O'Donnell J.A. Realistic expectations for the patient with intermittent claudication. Br J Surg 78 (1991) 861-863
19. Hagman M, Wilhelmsen L, Pennert K, Wedel H. Factors of importance for prognosis in men with angina pectoris derived from a random population sample. The Multifactor Primary Prevention Trial, Gothenburg, Sweden.
20. Kannel W.B., and McGee D.L. Update on some epidemiologic features of intermittent claudication. J Am Geriatr Soc 33 (1985) 13-18
21. Mohler III E.R. Peripheral artery disease: identification and implications. Arch Intern Med 163 (2003) 2306-2314
22. Murabito J.M., D'Agostino R.B., Silbershatz H., and Wilson P.W. Intermittent claudication. A risk profile from the Framingham Study. Circulation 96 (1997) 44-49
23. Peabody C.N., Kannel W.B., and McNamara P.M. Intermittent claudication: surgical significance. Arch Surg 109 (1974) 693-697
24. Kannel W.B. Epidemiologic relation of cardiovascular disease among different vascular territories. Atherothrombosis and cardiovascular disease. 2nd Edition (2005), Lippincott Williams & Wilkins, London Chap 98 1493-1496
25. Wilson P.W.F., D'Agostino R.B., Levy D., Belanger A.M., Silbershatz H., and Kannel W.B. Prediction of coronary heart disease using risk factor categories. Circulation 97 (1998) 1837-1847
26. National Health and Nutrition Examination Survey NHANES III (1988-1994), CHC/NCHS. Heart Disease and Stroke Statistics-2003 Update American Heart Association.
27. Selvin E., and Erlinger T.P. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation 110 6 (2004) 738-743
28. McDermott M.M., Mehta S., Ahn H., and Greenland P. Atherosclerotic risk factors are less intensively treated in patients with peripheral arterial disease than in patients with coronary artery disease. J Gen Intern Med 12 4 (1997) 209-215
29. Hirsch A.T., Criqui M.H., Treat-Jacobson D., Regensteiner J.G., Creager M.A., Olin J.W., et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 286 (2001) 1317-1324
30. Hagman M., Wilhelmsen L., Pennert K., and Wedel H. Factors of importance for prognosis in men with angina pectoris derived from a random population sample. The multifactor primary prevention trial, Gothenberg Sweden. Am J Cardiol 61 (1988) 530-535
31. Leng G.C., Price J.F., and Jepson R.G. Lipid-lowering for lower limb atherosclerosis. Cochrane Database Syst Rev (2000) CD000123
32. Mehler P.S., Coll J.R., Estacio R., Esler A., Schrier R.W., and Hiatt W.R. Intensive blood pressure control reduces risk of cardiovascular events in patents with peripheral artery disease and type 2 diabetes. Circulation 107 (2003) 753-756
33. Ostergren J., Sleight P., Dagenais G., Danisa K., Bosch J., Davies R., et al. Impact of rampiril in patients with evidence of clinical or subclinical peripheral arterial disease. Eur Heart J 25 (2004) 17-24
34. Yusuf S., Sleight P., Pogue J., Bosch J., Davies R., and Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, rampiril on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 342 (2000) 145-153
35. Pedersen T.R., Kjekshus J., Pyorala K., Olsson A.G., Cook T.J., Musliner T.A., et al. Effect of Simvastatin on ischemic signs and symptoms in the Scandinavian simvastatin survival study (4S). Am J Cardiol 81 (1998) 333-335
36. Hirsch A.T., Haskal Z.J., Hertzer N.R., Bakal C.W., Creager M.A., Halperin J.L., et al., ACC/AHA. 2005 Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. J Am Coll Cardiol 47 (2006) 1239-1312
37. Vogt M.T., Cauley J.A., Kuller L.H., and Hulley S.B. Prevalence and correlates of lower extremity arterial disease in elderly women. Am J Epidemiol 137 (1993) 559-568
38. Pepine C.J. Clinical aspects of silent myocardial ischemia in patients with angina and other forms of coronary heart disease. Am J Med 80 (1986) 24-34
39. Deanfield J.E., Maseri A., Selwyn A.P., Ribiero P., Chierchia S., Krickler S., et al. Myocardial ischemia during daily life in patients with stable angina: its relation to symptoms and heart rate changes. Lancet 2 (1983) 753-758
40. Cecchi A.C., Dovellini E.V., Marchi F., Pucci P., Santoro G.M., and Fazzini P.F. Silent myocardial ischemia during ambulatory electrocardiographic monitoring in patients with effort angina. J Am Coll Cardiol 1 (1983) 934-939
41. Murabito J.M., Evans J.C., Larson M.G., Nieto K., Levy D., and Wilson P.W.F. The ankle-brachial index in the elderly and risk of stroke, coronary disease, and death-the Framingham study. Archives of Internal Medicine 163 (2003) 1939-1943